|  Help  |  About  |  Contact Us

Publication : Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

First Author  Christadoss P Year  1985
Journal  Immunogenetics Volume  21
Issue  1 Pages  33-8
PubMed ID  3917973 Mgi Jnum  J:100213
Mgi Id  MGI:3588341 Doi  10.1007/BF00372239
Citation  Christadoss P, et al. (1985) Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. Immunogenetics 21(1):33-8
abstractText  Immune response (Ir) gene(s) at the I-A subregion of the mouse H-2 complex influence susceptibility to experimental autoimmune myasthenia gravis (EAMG). To determine the importance of the Ir gene product, the Ia antigens, in EAMG pathogenesis, we studied the degree of EAMG susceptibility of an I-A mutant strain, the B6.C-H-2bm12 (bm12), and its parent B6/Kh. According to the cellular, humoral, biochemical, and clinical manifestations of EAMG, the I-A mutation converted an EAMG susceptible strain (B6/Kh) into a relatively resistant strain (bm12). The relative resistance to EAMG induction in bm12 may be due to the lack of Ia.8 and/or Ia.39 determinants and/or quantitative expression of Ia antigens.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression